PL313084A1
Pharmaceutic formulation of nerve growth factor
Abstract
Aqueous formulations of nerve growth factor suitable for lyophilization and subsequent reconstitution in which nerve growth factor is admixed with sugars and buffer are provided.
Term
Term ended
Projected expiry passed 16 August 2014, 12.1 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
57 members in 32 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 10979893 | United States of America | A | |
| 10979893 | United States of America | A | |
| 9409245 | United States of America | W | |
| 9409245 | United States of America | W | |
| 109798 | – | – | – |
| US19930109798 | – | – | – |
| WO1994US09245 | – | – | – |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| IL110725D0 | Israel | D0 | |
| CA2169834A1 | Canada | A1 | |
| WO9505845A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7566894A | Australia | A | |
| NO960651D0 | Norway | D0 | |
| NO960651L | Norway | L | |
| ZA946333B | South Africa | B | |
| FI960750A | Finland | A | |
| HU9600371D0 | Hungary | D0 | |
| CZ42496A3 | Czechia | A3 | |
| PL313084A1This record | Poland | A1 | |
| LV11279A | Latvia | A | |
| EP0721343A1 | European Patent Office (EPO) | A1 | |
| LT96011A | Lithuania | A | |
| BR9407278A | Brazil | A | |
| SK18396A3 | Slovakia | A3 | |
| CN1133012A | China | A | |
| LV11279B | Latvia | B | |
| LT4051B | Lithuania | B | |
| NZ271873A | New Zealand | A | |
| SI9420048A | Slovenia | A | |
| BG100371A | Bulgaria | A | |
| HUT74728A | Hungary | A | |
| AU677699B2 | Australia | B2 | |
| JPH10508000A | Japan | A | |
| IL124941D0 | Israel | D0 | |
| RU2126265C1 | Russian Federation | C1 | |
| PL176387B1 | Poland | B1 | |
| RO114742B1 | Romania | B1 | |
| HK1012990A1 | Hong Kong, China | A1 | |
| BG62951B1 | Bulgaria | B1 | |
| TW427905B | Taiwan Province of China | B | |
| US2001007662A1 | United States of America | A1 | |
| US6277828B1 | United States of America | B1 | |
| UA43348C2 | Ukraine | C2 | |
| KR100341193B1 | Republic of Korea | B1 | |
| EP0721343B1 | European Patent Office (EPO) | B1 | |
| AT226085T | Austria | T | |
| ATE226085T1 | Austria | T1 | |
| DE69431562D1 | Germany | D1 | |
| PT721343E | Portugal | E | |
| DK0721343T3 | Denmark | T3 | |
| ES2181723T3 | Spain | T3 | |
| DE69431562T2 | Germany | T2 | |
| CZ292422B6 | Czechia | B6 | |
| SI9420048B | Slovenia | B | |
| FI113241B | Finland | B | |
| CN1163265C | China | C | |
| SK284064B6 | Slovakia | B6 | |
| IL110725A | Israel | A | |
| NO317627B1 | Norway | B1 | |
| US7074763B2 | United States of America | B2 | |
| IL124941A | Israel | A | |
| JP2007314572A | Japan | A | |
| CA2169834C | Canada | C | |
| JP4592830B2 | Japan | B2 | |
| HU228152B1 | Hungary | B1 |
Numbers
- Publication, DOCDB
- 313084
- Publication, EPODOC
- PL313084
- Application
- 94313084
- Application, DOCDB
- 31308494
- Application, EPODOC
- PL19940313084
Titles
- English
- PHARMACEUTIC FORMULATION OF NERVE GROWTH FACTOR
Classification
- CPC, 11
- A61K9/0019
- A61K38/18
- A61K9/19
- A61K38/185
- A61K47/02
- A61K47/12
- A61K47/26
- A61K47/42
- Y10S530/839
- A61P25/00
- A61P25/28
- IPC, 13
- A61K9 08
- A61K9 00
- A61K9 14
- A61K9 19
- A61K38 18
- A61K38 22
- A61K47 00
- A61K47 02
- A61K47 12
- A61K47 26
- A61K47 42
- A61P25 28
- C07K